KCM
BIOC

Kennedy Capital Management’s Biocept, Inc. BIOC Stock Holding History

Kennedy Capital Management’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-26
Closed -$1.8M – 756
2015
Q2 		$1.8M Buy
26
+2
+8% +$154K 0.03% 606
2015
Q1 		$1.46M Buy
+24
New +$1.61M 0.03% 619

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
CC
Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Kennedy Capital Management's BIOC Position: Q3 2015 in Review

Kennedy Capital Management sold out of Biocept, Inc. (BIOC) in Q3 2015, closing a stake of 26 shares — an estimated $1.8M sold.

Kennedy Capital Management first reported a position in BIOC in Q1 2015 and held it in 2 quarters. The position peaked at $1.8M in Q2 2015. 17 funds tracked by Wall St. Rank hold BIOC as of Q3 2015.

  • Kennedy Capital Management reported no remaining Biocept, Inc. position as of Q3 2015 after selling out during the quarter.
  • Kennedy Capital Management sold 26 Biocept, Inc. shares in Q3 2015, an estimated $1.8M.
  • Kennedy Capital Management first reported a position in Biocept, Inc. in Q1 2015 and held it in 2 quarters.
  • Kennedy Capital Management's Biocept, Inc. position peaked at $1.8M in Q2 2015.
  • 17 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2015.

Based on Kennedy Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.